发明名称 Substituted isoxazolines and their use as antibacterial agents
摘要 Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, wherein, for example, X is O, S or NH; HET is an optionally substituted C-linked 5-membered heteroaryl ring containing 2 to 4 heteroatoms independently selected from N, O and S; Q is selected from, for example, Q1 and Q2: R<SUP>2 </SUP>and R<SUP>3 </SUP>are independently hydrogen or fluoro; T is selected from a range of groups, for example, an N-linked (fully unsaturated) 5-membered heteroaryl ring system or a group of formula (TC5): wherein Rc is, for example, R<SUP>13</SUP>CO-, R<SUP>13</SUP>SO<SUB>2</SUB>- or R<SUP>13</SUP>CS-; wherein R<SUP>13 </SUP>is, for example, optionally substituted ( 1 - 10 C)alkyl or R<SUP>14</SUP>C(O)O( 1 - 6 C)alkyl wherein R<SUP>14 </SUP>is optionally substituted ( 1 - 10 C)alkyl; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
申请公布号 US2007281916(A1) 申请公布日期 2007.12.06
申请号 US20050238260 申请日期 2005.09.29
申请人 ASTRAZENECA AB 发明人 GRAVESTOCK MICHAEL B.;BETTS MICHAEL J.
分类号 A61K31/496;A61K31/422;A61K31/4439;A61K31/5377;A61K31/541;A61P31/04;C07D261/08;C07D261/12;C07D261/14;C07D413/14 主分类号 A61K31/496
代理机构 代理人
主权项
地址